Cargando…

Immune modulating nanoparticles for the treatment of ocular diseases

Ocular diseases are increasingly influencing people’s quality of life. Complicated inflammatory mechanisms involved in the pathogenic process of ocular diseases make inflammation-targeting treatment a potential therapeutic approach. The limited efficacy of conventional anti-inflammatory therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Lianfei, Liu, Jin, Liu, Zeyang, Zhou, Huifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694601/ https://www.ncbi.nlm.nih.gov/pubmed/36424630 http://dx.doi.org/10.1186/s12951-022-01658-5

Ejemplares similares

The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases
por: Liu, Jin, et al.
Publicado: (2022)

Nanotechnology-based strategies for treatment of ocular disease
por: Weng, Yuhua, et al.
Publicado: (2017)

Ocular immune privilege
por: Zhou, Ru, et al.
Publicado: (2010)

The Role of Endogenous Antimicrobial Peptides in Modulating Innate Immunity of the Ocular Surface in Dry Eye Diseases
por: Eshac, Youssof, et al.
Publicado: (2021)

Breakthrough of extracellular vesicles in pathogenesis, diagnosis and treatment of osteoarthritis
por: Liu, Zichang, et al.
Publicado: (2022)

HMBG1 as a Driver of Inflammatory and Immune Processes in the Pathogenesis of Ocular Diseases
por: Liu, Yi, et al.
Publicado: (2018)

Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy
por: Swetledge, Sean, et al.
Publicado: (2021)

Lipid Nanoparticles for Ocular Gene Delivery
por: Wang, Yuhong, et al.
Publicado: (2015)

Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
por: Schneider-Futschik, Elena K., et al.
Publicado: (2021)

Role of immune cells in the ocular manifestations of pemphigoid diseases
por: Bose, Tanima
Publicado: (2019)

Modulating Immune Response with Nucleic Acid Nanoparticles
por: Durbin, Jake K., et al.
Publicado: (2019)

Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation
por: Wang, Xudong, et al.
Publicado: (2023)

Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases
por: Wan, Chen-rei, et al.
Publicado: (2021)

Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
por: Bachu, Rinda Devi, et al.
Publicado: (2018)

Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours
por: Giannaccare, Giuseppe, et al.
Publicado: (2021)

Genome editing in the treatment of ocular diseases
por: Choi, Elliot H., et al.
Publicado: (2023)

The Use of Polymer Blends in the Treatment of Ocular Diseases
por: Arribada, Raquel Gregorio, et al.
Publicado: (2022)

Screening, Diagnosis, and Treatment of Pediatric Ocular Diseases
por: Lam, Matthew, et al.
Publicado: (2022)

Role of Choline in Ocular Diseases
por: Hwang, Jin-Sun, et al.
Publicado: (2021)

Engineered Cell Membrane‐Derived Nanoparticles in Immune Modulation
por: Yang, Yixiao, et al.
Publicado: (2021)

Neutrophil Extracellular Traps (NETs) in Ocular Diseases: An Update
por: Zeng, Jia, et al.
Publicado: (2022)

Roles of Exosomes in Ocular Diseases
por: Liu, Jia, et al.
Publicado: (2020)

Exosomes and autophagy in ocular surface and retinal diseases: new insights into pathophysiology and treatment
por: Ma, Shisi, et al.
Publicado: (2022)

Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review
por: Wen, Ji, et al.
Publicado: (2021)

Oxidative Stress in the Anterior Ocular Diseases: Diagnostic and Treatment
por: Dammak, Azza, et al.
Publicado: (2023)

Discovery of CTSK(+) Periosteal Stem Cells Mediating Bone Repair in Orbital Reconstruction
por: Liu, Zeyang, et al.
Publicado: (2023)

Substrate stiffness can affect the crosstalk between adipose derived mesenchymal stem cells and macrophages in bone tissue engineering
por: Liu, Zeyang, et al.
Publicado: (2023)

Circular RNAs: Novel Promising Biomarkers in Ocular Diseases
por: Guo, Nan, et al.
Publicado: (2019)

DJ-1 in Ocular Diseases: A Review
por: Liu, Cong, et al.
Publicado: (2018)

The association between nuclear receptors and ocular diseases
por: Liu, Ke, et al.
Publicado: (2017)

Optimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review
por: Schechter, Barry, et al.
Publicado: (2022)

Diathesis and Ocular Disease
Publicado: (1909)

Update on the application of amniotic membrane in immune-related ocular surface diseases
por: Chen, Ziyan, et al.
Publicado: (2021)

Contact lenses for the treatment of ocular surface diseases
por: Sah, Ramkishor, et al.
Publicado: (2023)

Updates in the treatment of ocular allergies
por: Kari, Osmo, et al.
Publicado: (2010)

Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights
por: Giannaccare, Giuseppe, et al.
Publicado: (2020)

Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases
por: Zhu, Lucy, et al.
Publicado: (2014)

Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases
por: Patel, Chirag, et al.
Publicado: (2023)

Application of Convergent Science and Technology toward Ocular Disease Treatment
por: Bal-Öztürk, Ayça, et al.
Publicado: (2023)

Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review
por: Demarinis, Giuseppe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rbk5dl6ufao1uhtficr75rq4mc